P. A. Philip

Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor   Induction In Vivo

P. A. Philip, Daniel Rea, P. Thavasu et al. · JNCI Journal of the National Cancer Institute · 1993 · 187 citations

Phase III study of gemcitabine [G] plus cetuximab [C] versus gemcitabine in patients [pts] with locally advanced or metastatic pancreatic adenocarcinoma [PC]: SWOG S0205 study

P. A. Philip, Jacqueline Benedetti, Cecilia M. Fenoglio‐Preiser et al. · Journal of Clinical Oncology · 2007 · 187 citations

Surgical Oncology, Cancer Management, Adjuvant Chemotherapy +16

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial

Harry H. Yoon, Johanna C. Bendell, Fadi S. Braiteh et al. · Annals of Oncology · 2016 · 143 citations · Full text

Advanced Esophageal, Surgical Oncology, Esophagus +9

MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

S. Ali, Husain A. Saleh, Sean K. Sethi et al. · British Journal of Cancer · 2012 · 117 citations · Full text

Microrna Profiling, Tumor Biology, Engineering +11

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

Bassel F. El‐Rayes, Mark M. Zalupski, T. Bekai-Saab et al. · Annals of Oncology · 2010 · 97 citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Medicine +9